Table 7.
Studies evaluating dairy products intake.
| Reference | Country | Age | Cases/ Controls or total cohort | Type of study | Exposure | Contrast | OR (95% CI) | P for trend | Covariates considered* | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | B | E | S | H | R | |||||||||
| Zheng et al., 1995[29] | United States | 55–69 | 216/23,070 | Cohort | Dairy products | Q3 vs. Q1 | 1.1 | >0.05 | 1 | 1 | 1 | 2 | ||
| Potischman et al., 1993 [33] | United States | 20–74 | 399/296 | Population- based cc | Dairy foods | >17.6 vs. <6 times/month | 1.2 (0.7–2.0) | 1 | 1 | 1 | 1 | 1 | 1 | |
| Goodman et al., 1997 [34] | United States | 18–84 | 332/511 | Population- based cc | Dairy products | >301 vs. <60 g/day | 0.7 | 0.28 | (A) | 1 | 1 | 1 | ||
| McCann et al., 2000 [35] | United States | 40–85 | 232/639 | Population- based cc | Dairy | >56 vs. <32 times/month | 0.8 (0.5–1.3) | 0.25 | 1 | 1 | 1 | 1 | 3 | |
| Littman et al., 2001[36] | United States | 45–74 | 679/944 | Population- based cc | Dairy products | >2.4 vs. <1.2 servings/day | 1 (0.78–1.4) | 0.78 | 1 | 1 | 1 | 1 | 1 | |
| Terry et al., 2002[20] | Sweden | 50–74 | 709/2,877 | Population- based cc | Dairy products | Q4 vs. Q1 (35 vs. 5 median consumption per week) | 0.9 (0.7–1.2) | 0.3 | 1 | 1 | 1 | |||
| Tzonou et al., 1996[30] | Greece | 145/298 | Hospital- based cc | Dairy products | Per quartile | 0.94 (0.74–1.19) | 1 | 1 | 1 | 1 | 1 | 5 | ||
| Petridou et al., 2002 [31] | Greece | 84/84 | Hospital- based cc | Dairy products | Per quartile | 1.21 (0.86–1.69) | (A) | 1 | 1 | 1 | ||||
| Salazar-Martinez et al., 2005 [38] | Mexico | 18–81 | 85/629 | Hospital- based cc | Dairy products | T3 vs. T1 | 0.5 (0.23–1.13) | 0.23 | 1 | 1 | 1 | 1 | ||
*
Adjustment columns: A = Age; B = BMI/weight; E = Total Energy; S = Smoking; H = HRT/ERT use; R = Reproductive factors; (A): matched on age. Numbers in columns refer to the number of covariates adjusted for under that grouping. Abbreviations: Q: quantile; T: tertile; cc: case-control.